Aptus Pharma share price
You have to be logged in to add this to Watchlist.- ₹241.80(-1.99%)February 9, 2026 13:15:00 PM IST
- NSE
- BSE
- Vol : 10.00 K (NSE + BSE)Last 20 day avg : 18.90 K
Aptus Pharma is trading -1.99% lower at Rs 241.80 as compared to its last closing price. Aptus Pharma has been trading in the price range of 242.00 & 241.80. Aptus Pharma has given 45.55% in this year & -8.34% in the last 5 days. The company posted a net profit of 1.75 Crores in its last quarter.Listed peers of Aptus Pharma include Sun Pharmaceutical Industries (0.58%), Divi's Laboratories (1.45%), Torrent Pharmaceuticals (1.42%).The Mutual Fund holding in Aptus Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Aptus Pharma was at 10.03% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 09, 2026, 09:29 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,704.50 | 0.58 | 4,08,908.76 | 33.97 | 5.41 | 1.01 | 0.50 |
| Divi's Laboratories | Moderately Bearish | 6,112.40 | 1.45 | 1,62,209.82 | 72.02 | 10.56 | 0.50 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 3,995.50 | 1.42 | 1,35,495.58 | 70.01 | 17.78 | 0.80 | 17.62 |
| Cipla | Moderately Bearish | 1,337.10 | 0.47 | 1,08,007.17 | 20.12 | 3.4 | 0.99 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,277.25 | 2.91 | 1,06,559.54 | 17.40 | 2.93 | 0.68 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-10 | Half Yearly Results |
- IndustryBiotechnology & Drugs
- ISININE15XJ01010
- BSE Code544529
- NSE Code
Aptus Pharma is trading at 241.80 as on Mon Feb 09 2026 07:45:00. This is -1.99% lower as compared to its previous closing price of 246.70.
The market capitalization of Aptus Pharma is 165.88 Cr as on Mon Feb 09 2026 07:45:00.
The 52 wk high for Aptus Pharma is 270.50 whereas the 52 wk low is 80.80
Aptus Pharma can be analyzed on the following key metrics -
- TTM P/E: 16.44
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: 0.37
Aptus Pharma reported a net profit of 3.10 Cr in 2025.
EQUITY QUICK LINKS
Aptus Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.